mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |